About the Authors
- Aaltje Y. Adema
-
Affiliation Department of Nephrology, VU University Medical Center, Amsterdam, The Netherlands
- Frans J. van Ittersum
-
Affiliation Department of Nephrology, VU University Medical Center, Amsterdam, The Netherlands
- Joost G. Hoenderop
-
Affiliation Department of Physiology, Radboud university medical center Nijmegen, The Netherlands
- Martin H. de Borst
-
Affiliation Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, Groningen, The Netherlands
- Prabath W. Nanayakkara
-
Affiliation Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands
- Piet M. Ter Wee
-
Affiliation Department of Nephrology, VU University Medical Center, Amsterdam, The Netherlands
- Annemieke C. Heijboer
-
Affiliation Department of Clinical Chemistry, VU University Medical Center, Amsterdam, The Netherlands
- Marc G. Vervloet
-
* E-mail: m.vervloet@vumc.nl
Affiliations Department of Nephrology, VU University Medical Center, Amsterdam, The Netherlands, Institute for Cardiovascular Research VU (ICaR-VU), Amsterdam. The Netherlands
- NIGRAM consortium
-
¶Membership of the NIGRAM consortium is listed in the Acknowledgments.
Competing Interests
The authors have the following interests: Co-author Dr. Marc G. Vervloet received research support from Fresenius, Shire, Sanofi, AbbVi and Amgen. Dr. Marc G. Vervloet also received speakers fees from Baxter and Amgen and served as consultant for Astellas, Amgen, Fresenius and AbbVie. All other authors declare that no competing interests exist. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.
Author Contributions
Conceived and designed the experiments: AA PMTW MGV. Analyzed the data: AA FJvI JGH MHdB MGV. Contributed reagents/materials/analysis tools: PWN ACH. Wrote the paper: AA FJvI MHdB MGV.